No artigo: “Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil” publicado no periodico “Revista de Saúde Pública”, volume 49 de 2015, em Conclusions of the Abstract.

Where it reads:

“After matching, the study indicated better survival of patients treated with regimens using tacrolimus. However, regimens containing cyclosporine were more cost-effective.”

It should read:

“After matching, the study did not indicate better survival of patients treated with regimens using tacrolimus. Moreover, regimens containing cyclosporine were more cost-effective.”

Publication Dates